Miravalle A - Search Results

1

Encephalitis complicating smallpox vaccination.

Miravalle A, Roos KL. Miravalle A, et al. Arch Neurol. 2003 Jul;60(7):925-8. doi: 10.1001/archneur.60.7.925. Arch Neurol. 2003. PMID: 12873847 Review.

2

Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy.

Miravalle A, Jensen R, Kinkel RP. Miravalle A, et al. Arch Neurol. 2011 Feb;68(2):186-91. doi: 10.1001/archneurol.2010.257. Epub 2010 Oct 11. Arch Neurol. 2011. PMID: 20937940

3

Acute disseminated encephalomyelitis: yellow fever vaccination.

Miravalle A, Biller J, Silva E, Conneely M, O'Keefe P. Miravalle A, et al. Arq Neuropsiquiatr. 2009 Sep;67(3A):710-1. doi: 10.1590/s0004-282x2009000400029. Arq Neuropsiquiatr. 2009. PMID: 19722058 Free article. No abstract available.

4

Neurologic complications of vaccinations.

Miravalle AA, Schreiner T. Miravalle AA, et al. Handb Clin Neurol. 2014;121:1549-57. doi: 10.1016/B978-0-7020-4088-7.00103-6. Handb Clin Neurol. 2014. PMID: 24365435 Review.

5

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis.

Prosperini L, Kinkel RP, Miravalle AA, Iaffaldano P, Fantaccini S. Prosperini L, et al. Among authors: miravalle aa. Ther Adv Neurol Disord. 2019 Mar 29;12:1756286419837809. doi: 10.1177/1756286419837809. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30956686 Free PMC article.

6

Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis.

Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP. Nielsen AS, et al. Among authors: miravalle a. Mult Scler. 2012 Mar;18(3):377-8. doi: 10.1177/1352458511418631. Epub 2011 Aug 9. Mult Scler. 2012. PMID: 21828201 Clinical Trial. No abstract available.

7

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.

Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Kleinschmidt-DeMasters BK, et al. Among authors: miravalle a. J Neuropathol Exp Neurol. 2012 Jul;71(7):604-17. doi: 10.1097/NEN.0b013e31825caf2c. J Neuropathol Exp Neurol. 2012. PMID: 22710964 Review.

8

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.

Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL. Honce JM, et al. Among authors: miravalle a. Neurology. 2019 Feb 12;92(7):e723-e732. doi: 10.1212/WNL.0000000000006916. Epub 2019 Jan 11. Neurology. 2019. PMID: 30635477 Free PMC article. Clinical Trial.

9

Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.

Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Alvarez E, et al. Among authors: miravalle a. Mult Scler Relat Disord. 2021 Oct;55:103170. doi: 10.1016/j.msard.2021.103170. Epub 2021 Jul 24. Mult Scler Relat Disord. 2021. PMID: 34364034

10

Remyelination Therapy in Multiple Sclerosis.

Harlow DE, Honce JM, Miravalle AA. Harlow DE, et al. Among authors: miravalle aa. Front Neurol. 2015 Dec 10;6:257. doi: 10.3389/fneur.2015.00257. eCollection 2015. Front Neurol. 2015. PMID: 26696956 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page